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Abstract
Exposure to polycyclic aromatic hydrocarbons (PAHs) has been associated with adverse health 
outcomes. Concentrations of urinary PAH metabolites (OH-PAHs) provide an integrated measure 
of human exposure to PAHs but measurement of urinary OH-PAHs has not been done in Australia 
and rarely in Vietnam, where air pollution is of concern. In this study, we assessed exposure to 
PAHs in 16 participants living in Brisbane, Australia and Hanoi, Vietnam, with 4 participants 
travelling between the two cities during the monitoring period. A total of 312 first morning urine 
samples were collected over 10 weeks and were analysed for nine OH-PAHs. Concentrations of 
the urinary OH-PAHs were 3-10 times higher in participants from Hanoi than those from 
Brisbane. For example, the median concentrations of 1-hydroxypyrene were 292 pg/mL in Hanoi, 
compared to 64 pg/mL in Brisbane. For participants travelling from Brisbane to Hanoi and back, 
differences in exposure to PAHs in these two cities resulted in corresponding changes of urinary 
OH-PAH concentrations, demonstrating that the more polluted environment in Hanoi was likely 
the source for higher PAH exposure there.
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Polycyclic aromatic hydrocarbons (PAHs), a class of hazardous air pollutants, are 
predominantly produced during the incomplete combustion of organic materials, e.g. fossil 
fuel, coal, and wood. PAHs are widely distributed in the atmosphere and they can be 
transported over long distances before depositing through atmospheric precipitation onto 
soils, vegetation or waters (Ravindra et al., 2008).
Exposure to PAHs is associated with a variety of health effects including lung, skin and 
bladder cancers in humans (Agudo 2006; IARC, 2010; Kim et al., 2013). Recent findings 
are suggestive of relationships between PAHs in placenta and the risk of neural tube defects 
and the alteration of the immune system (Langlois et al., 2012; Walker et al., 2013). Other 
study suggests that exposure to polycyclic aromatic hydrocarbons encountered in New York 
City air may play a role in childhood Attention Deficit Hyperactivity Disorder behaviour 
problems (Perera et al., 2014).
Due to the ubiquitous presence of PAHs in the atmosphere, exposure to atmospheric PAHs 
may likely impact large populations; as a consequence, it could be a major public health 
issue. This is especially important in developing countries, where severe air pollution from 
fossil fuel combustion, e.g. coal burning power plants and motor vehicles (Gurjar et al., 
2010; Han and Naeher, 2006), usually exceeds air quality standards (Hopke et al., 2008). For 
example Vietnam ranked among the ten worst countries in the world in terms of air pollution 
(Emerson, 2012), with traffic emissions responsible for 70% of all urban air pollution 
(MoNRE, 2007). One study reported that atmospheric PAHs concentrations at 10 different 
roadside sites in Hanoi were significantly higher than those from other countries, and often 
exceeded the recommended maximum thresholds set by the World Health Organisation 
(Kishida et al. 2008). At the same time, developed countries like Australia are considered 
relatively clean in terms of air pollution with levels of atmospheric PAHs similar to other 
countries in Europe (Berko, 1999). Levels of atmospheric PAHs in Brisbane, a metropolitan 
city in Australia, have decreased throughout the last decade (Kennedy et al. 2010; Muller et 
al. 1998; Wang et al., 2013) probably due to strict emission regulations (Hopke et al., 2008).
To study the actual exposure to PAHs, urinary mono-hydroxylated PAHs (OH-PAHs), a 
group of PAH metabolites, have been used as biomarkers (Jacob and Seidel, 2002). Among 
the OH-PAHs, 1-hydroxypyrene (1-PYR) is the most commonly used PAH biomarker in 
both occupational as well as in the general population from various countries (Hansen et al. 
2008). The use of PAH metabolites as biomarkers is more important when one wants to 
access the actual change in human exposure to different levels of PAHs (e.g. in different 
level of air pollution).
However, to our knowledge, there is no study to date using PAH metabolites to assess 
general human exposure to PAHs in Australia. There are only two known studies in Vietnam 
assessing PAH exposure by biomonitoring urinary OH-PAHs. One study systematically 
monitored 1-PYR urinary concentrations in 44 street workers in Hanoi over 4 weeks and 
consistently showed concentrations of 1-PYR up to 24 times higher than those in the US 
population. The study suggested substantially higher exposure to PAHs in Hanoi even when 
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the workers wore activated carbon respirators to reduce exposure to PAHs and other air 
pollutants (Wertheim et al. 2012). The other study only analysed random spot urine samples 
of 23 middle-age people in Hanoi to compare the levels with those from other countries in 
Asia (Guo et al., 2013).
In this study, we report urinary concentrations of PAH metabolites in a small group of 
residents in Brisbane, Australia, and Hanoi, Vietnam, and those travelling between the two 
cities. Our goals were to assess a) the exposure to PAHs in the two cities through 
biomonitoring of urinary OH-PAH concentrations; b) the change of OH-PAH profile when 
people travelled between the two cities; and c) the influence of age on the concentrations of 
OH-PAHs.
2. Materials and Methods
2.1. Study participants
We recruited 16 healthy volunteers (9 adults and 7 children) representing 5 families (Table 
1). Three families lived in metropolitan Brisbane and two families lived in metropolitan 
Hanoi. Their homes were not close to any heavy emission source or heavy traffic (at least 1 
km away from heavy traffic). During the study, one family in Brisbane (two adults and two 
children) travelled to Hanoi, and then back to Brisbane. All participants were of Vietnamese 
origin, i.e. there was no race difference that could significantly affect the metabolism of 
PAHs. The adults were aged between 28 and 35 years and the children aged between 2 and 8 
years. Participants gave written informed consent prior to inclusion; parents or guardians 
provided consent on behalf of their children. This study was approved by the Medical 
Research Ethics Committee of the University of Queensland (#2011000795), and the 
Internal Review Boards of the Centers for Disease Control and Prevention and the National 
Institute of Environmental and Occupational Health (Vietnam).
All participants had no known occupational exposure to PAHs and all were non-smokers. 
The volunteers were instructed to avoid food with known high PAH-content (e.g. grilled or 
smoked food) during the study period. Participants from the travelling family (from 
Brisbane to Hanoi) took food from Brisbane to ensure that their diet in the first week in 
Hanoi was similar to their diet in Brisbane. Information about the participants is shown in 
Table 1.
A total of 312 urine samples were collected during the study period. In general, we asked the 
participants to collect first-morning urine voids twice a week (Tuesday and Friday) for 10 
weeks in August and September 2011. The travelling family collected additional samples for 
one week in July 2011 and samples before and around 6 hours after their flights. There were 
occasions when the participants missed the sampling date and no sample was collected. 
After collection, the samples were frozen immediately in the freezer compartment of the 
participant’s refrigerator and then transported to the laboratory, and stored at −80 °C.
2.2. Urine analysis
After all samples were collected, urine samples were shipped on dry ice to the Centers for 
Disease Control and Prevention (Atlanta, GA, USA) and analysed for nine OH-PAHs using 
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gas chromatography/high resolution mass spectrometry (GC-HRMS) according to a method 
described previously (Li et al., 2006). In brief, urine samples were spiked with 13C-labeled 
internal standards and sodium acetate buffer containing β-glucuronidase, urinary conjugates 
were hydrolysed overnight at 37 °C, and then the target analytes were extracted through 
semi-automated liquid–liquid extraction. The extracts were evaporated, and the target 
analytes were derivatised, and analysed on a 6890 gas chromatograph (Agilent Technology, 
Palo Alto, CA, USA) coupled with a MAT95XL high-resolution mass spectrometer 
(Thermo Fisher Scientific, Waltham, MA, USA). All analyses were subjected to a series of 
quality control and quality assurance checks as described elsewhere (Li et al., 2006). All 
concentrations were subtracted with a method blank prepared and analyzed in the same 
sample run. The limits of detection (LODs) for the measured OH-PAHs ranged from 2.6-18 
pg/mL. The overall coefficients of variation for 42 quality control samples prepared in 6 
batches over 3 weeks were 2.8-3.4% for the 9 OH-PAHs. Urinary creatinine was measured 
on a Roche Hitachi 912 Chemistry Analyzer (Hitachi, Pleasanton, CA, USA) using the 
Creatinine Plus Assay, as described in Roche’s Creatinine Plus Product Application no. 
03631761003.
Nine OH-PAHs, metabolites of naphthalene, 1-naphthol (1-NAP) and 2-naphthol (2-NAP), 
of fluorene, 9-hydroxyfluorene (9-FLU), 3-hydroxyfluorene (3-FLU), 2- hydroxyfluorene 
(2-FLU), of phenanthrene, 3-hydroxyphenanthrene (3-PHE), 1-hydroxyphenanthrene (1-
PHE), 2-hydroxyphenanthrene (2-PHE), and of pyrene (1-PYR), were measured in urine.
2.3. Data and statistical analysis
We used both unadjusted and creatinine-adjusted concentrations for data analyses. All 
statistical analyses were performed through GraphPad Prism (GraphPad, La Jolla, CA, 
USA). Because of the small sample size, Mann–Whitney U test was used to examine the 
differences between groups. Results were considered statistically significant at p < 0.05.
3. Results
3.1. Concentrations of OH-PAHs in the participants’ urine
OH-PAHs concentrations were detectable in most urine samples, with a detection rate over 
99% for all nine OH-PAHs. There were 11 samples in which one of the OH-PAHs 
concentrations was below the LOD. Values <LOD were replaced as LOD/squrt(2) in the 
statistical analysis (Hornung and Reed, 1990).
OH-PAHs urinary concentrations in samples collected in Hanoi and Brisbane are compared 
in Table 2 and stratified into two age groups (children and adults). Median unadjusted 
concentrations of the nine urinary OH-PAHs metabolites in samples collected in Hanoi were 
significantly higher (3 to 10 times, p < 0.01) than in samples collected in Brisbane for both 
age groups. No difference was observed between the unadjusted concentrations of the 
children and adults groups in the same cities. However, there were significant differences in 
concentrations of all urinary OH-PAHs between children and adults groups if the creatinine-
adjusted concentrations were used, with higher concentrations observed in children’s 
samples (p < 0.05).
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We summed the total concentrations of metabolites from each parent PAH, e.g. 1-NAP and 
2-NAP for naphthalene, to better reflect the exposure of the participants to the parent PAH. 
In this study, the total concentrations of metabolites of naphthalene (median values) were 
the highest followed, in decreasing order, by those of fluorene, phenanthrene and pyrene for 
both Hanoi and Brisbane samples.
3.2. Effect of travelling between cities
Figure 1 presents the urinary concentrations of 1-PYR (as a representative biomarker of OH-
PAHs) in samples of the participants who travelled from Brisbane to Hanoi (on 23 August 
2011) and then returned to Brisbane (07 September 2011 for father and son and 23 
September for mother and daughter). Before going to Hanoi, the travelling participants had 
lived in Brisbane for at least 6 months and the median concentration of 1-PYR in their 
samples was 87 pg/mL. After arriving in Hanoi, the urinary median concentration of 1-PYR 
increased to 532 pg/mL. When the travelling participants returned to Brisbane from Hanoi, 
their 1-PYR median concentrations decreased to 105 pg/mL, a concentration comparable 
with the concentration among people who stayed in Brisbane during the entire study period. 
The level of urinary 1-PYR in the travelling participants did not change significantly before 
they travelled and after they returned home. The same effect was observed for all other PAH 
metabolites measured (Fig. S1-4)
4. Discussion
This is the first study to monitor the biological response on urinary PAH biomarkers to the 
change in atmospheric PAH exposure for small groups of adults and children in a non-
occupational setting while maintaining a similar diet. It is also the first study, to the best of 
our knowledge, which reports urinary OH-PAHs levels in a small group of residents living 
in Australia.
4.1. Profiles of urinary PAH metabolites
The OH-PAHs observed consistently at the highest concentrations were 1-NAP and 2-NAP 
which likely reflected the fact that naphthalene is one of the most abundant PAH in the 
atmosphere (Buckpitt et al., 2010). It is also because metabolites of smaller PAHs (i.e., two 
to three aromatic rings) have been reported to be excreted preferentially in the urine, but 
metabolites of larger PAHs are excreted primarily in the feces as the molecular structure and 
size of PAHs can affect absorption efficiency, and metabolic and excretion pathway 
(Ramesh et al., 2004). Metabolites of naphthalene, 1-NAP and 2-NAP, accounted for 73% 
and 83% total concentration of OH-PAHs in residents of Hanoi and Brisbane, respectively. 
Similar to other studies (Guo et al., 2013; Li et al., 2011), concentrations of metabolites of 
the higher molecular weight PAHs were lower. On average, the sum of metabolites of 
napthalene, fluorene and phenanthrene contributed >96% to the total urinary OH-PAH 
concentrations with 1-PYR accounts for the remaining part.
4.2. Difference in PAH exposure between two cities and its impact to the travellers
The differences in urinary OH-PAH concentrations were likely reflective of the differences 
in atmospheric concentrations of the parent PAHs between the two cities. The limited data 
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available in the literature on atmospheric PAHs in the two cities, which were presented in 
Table 3, suggest that the ambient air concentrations of the parent PAHs (fluorene, 
phenanthrene, pyrene) in Hanoi were approximately 4.5 to 7.6 times higher than those 
measured in Brisbane around the period of this study (2011-2012). No data are available for 
naphthalene. The similar difference of urinary concentrations and the atmospheric 
concentrations of fluorene, phenanthrene and pyrene between the two cities indicated that 
OH-PAHs are good biomarkers for assessing population exposure to PAHs in the air. Albeit 
relying on a small sample size, this suggestive conclusion was specifically supported by the 
concentration profiles of travelling participants where food intake was controlled to remove 
its effect to the level of urinary OH-PAHs (see Figs. 1 and 2).
The urinary concentrations of OH-PAHs in Hanoi’s participants were lower compared with 
the data reported previously for this city. For example, Guo et al. (2013) recorded a median 
1-PYR urinary concentration of 463 pg/mL for a middle-aged population in Hanoi (n=23), 
compared to the 292 pg/mL measured in this study. Meanwhile Wertheim et al. (2012) also 
reported a much higher concentrations of OH-PAHs in middle-aged street workers in Hanoi 
(n=44) with median 1-PYR concentrations of 1020 ng/g creatinine compared to 407 ng/g 
creatinine in this study. This is not surprising because street workers are occupationally 
exposed to traffic exhaust especially in Vietnam where the majority of the urban vehicle 
fleet consists of scooters with low emission standard. Similarly, it has been reported that 
children attending school in a heavy traffic area had much higher urinary OH-PAH levels 
than those attending a school far away from heavy traffic (Fan et al., 2012). Additionally, we 
minimised the PAH dietary input in this study by asking participants to eat low PAH-
containing food, and the travel family further reduced dietary influence in Hanoi by bringing 
food to Hanoi during the sampling period. Therefore, the potentially lower dietary exposure 
could also contribute to the lower urinary OH-PAH level in this study compared to other 
reported levels for Hanoi.
Meanwhile, the urinary concentrations of OH-PAHs in participants from Brisbane, even 
with a small sample size, were comparable to those in more developed countries like Japan, 
Korea, Malaysia, Germany, and the United States as shown in Table 4. For example, median 
concentration of 1-PYR in Brisbane (101 urine samples from 6 participants) was 59 pg/mL 
while the corresponding values in Japan, Korea, Malaysia, were 75, 103, 65 pg/mL 
respectively (Guo et al., 2013). The urinary concentrations of 1-PYR in German and 
American populations were 140 and 113 pg/mL, respectively (CDC, 2015; Wilhelm et al., 
2008).
We examined the impact of travel from Brisbane to Hanoi on urinary OH-PAH 
concentrations. As shown in Fig. 1 and 2, the urinary levels of 1-PYR among the travellers 
were similar to those of local participants. While in Hanoi, the median 1-PYR concentration 
increased by 5 folds within the same participants who consumed the same type of food 
during the sampling period. The same effect was observed for all other PAH metabolites 
measured in this study (Fig. S5). This suggests that urinary OH-PAH concentrations 
reflected the exposure to PAHs accurately, and that these PAH metabolites are effective 
biomarkers for monitoring PAH exposure. Furthermore, the more polluted ambient air in 
Hanoi contributed to the higher PAH exposure in the travellers while they were in Hanoi.
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Vehicle exhaust was likely the main cause of higher exposure to PAHs in Hanoi compared 
to Brisbane. An earlier analysis of PAH and nitro-PAHs in atmospheric particulate matter 
showed that several million motorbikes with no-catalytic converter, and a poorly maintained 
car fleet were major pollution sources in Vietnam (Pham et al. 2013; Thuy et al. 2012). 
Raising Vietnam’s emission standard for motor vehicles is essential to improve air quality 
and reduce the human exposure to PAHs in Hanoi and in Vietnam in general. The current 
standard in Vietnam is Euro 2 which allows the emission of pollutants such as hydrocarbon 
several times higher than the Euro 5/6 standard applied in Australia (Delphi, 2015). 
Additionally, many low income people in Vietnam cook with poor quality fuels (e.g. 
beehive coal or coal briquette), which could emit high level of PAHs and contribute to 
indoor and outdoor air pollution (Kim Oanh and Dung, 1999).
4.3. Comparison between adults and children
This is the first study, to the best of our knowledge, followed entire families–both children 
and adults–over several months. The children and adults from the same families had similar 
environment and dietary intake. Both groups spent approximately the same amount of time 
indoor and outdoor although at different places during weekday (office/workplace for adults 
and school for children in daytime and at home in nighttime). This condition allowed a close 
examination of the effect of age on PAH biomarker levels. Our study found no significant 
differences between the unadjusted urinary concentrations (in pg/mL) of OH-PAHs in 
children compared with adults in both Brisbane and Hanoi (Table 3). For example, median 
1-PYR concentrations in Hanoi was 292 pg/mL for both adult (74 samples from 5 adults) 
and children (87 samples from 6 children). It is not surprising because all participants were 
non-smokers and their diets and environments were similar (no special diet for children was 
recorded in any family participating in this study).
However, there were significant differences between adults and children if the OH-PAHs 
urinary concentrations were creatinine-adjusted. This could be caused by the lower level of 
urinary creatinine in children than in adults as reported previously (Barr et al., 2005). 
Several other studies have recognized that creatinine adjustment increases the calculated 
adjusted concentrations of chemicals in children compared with adults (Barr et al., 2005, 
Heudorf and Angerer, 2001b). This finding raises doubts about comparing creatinine-
adjusted urine contaminants between different populations with biologically different 
creatinine levels – such as between children and adults. In such case, alternative adjustment 
methods should be considered to correct for urine dilution, e.g., specific gravity adjustment 
(Sauve et al., 2015, Suwazono et al., 2005).
4.4. Limitations
We acknowledge that there were some limitations to the study. First, the data were derived 
from a small number of participants, especially when stratified into children and adult 
groups. The participants were all non-smokers and students/office workers. Therefore the 
results are not likely to be representative for the whole population but rather provide an 
indication for similar sub-populations (e.g. students and office workers) in Brisbane and 
Hanoi. Second, there was no personal air monitoring data for direct comparison between 
ambient exposure and internal exposure although the ambient PAHs concentrations in the 
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two cities around the time of this study were documented. Third, we did not provide food 
nor measure the dietary intake of PAHs although the diet was kept similar among 
participants during the study period. The similarity of OH-PAH concentrations between the 
travelling group and the local resident groups suggested that dietary intake does not likely to 
have considerable impact on the urinary concentration of OH-PAHs in this study.
5. Conclusion
This is the first study, to the best of our knowledge, reporting levels of urinary OH-PAHs in 
Brisbane, Australia. Even with a small sample size, we found that the urinary OH-PAH 
levels in Brisbane were consistent with those in developed countries. We found 3-10 times 
higher levels in residents in Hanoi, Vietnam than those in Brisbane suggesting that PAH 
exposure in Hanoi was substantially higher than in Brisbane, most likely because of the 
higher ambient air PAH concentrations. Travelling from Brisbane to Hanoi and back while 
keeping similar diets resulted in corresponding changes in the concentration of urinary OH-
PAHs in the travellers; this demonstrated the effectiveness of the PAH metabolites as PAH 
exposure biomarkers and further confirmed that the more polluted environment in Hanoi 
was likely the source for the elevated PAH exposure there. This is also the first study that 
followed entire families–both children and adults–in various environments while kept 
similar diets, which allowed a close examination of age effects on exposure biomarkers. Our 
findings indicated no significant difference on the unadjusted urinary concentrations 
between children and adults, but the creatinine adjustment process could introduce bias as 
children and adults are biologically at different creatinine levels.
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The concentrations of urinary 1-hydroxypyrene in a family who traveled between Brisbane, 
Australia and Hanoi, Vietnam
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Urinary concentrations of 1-PYR of three husbands, one of whom travelled from Brisbane to 
Hanoi and back during the study period; the other two did not travel and remained at their 
regular place of residence for the whole study period
Thai et al. Page 12

























Thai et al. Page 13
Table 1
Participants’ information
Participant code Sex Age
(years)
Number of urine sample
Group 1 Travel: Australia – Vietnam - Australia
1 TV1 Male 33 30 (10+9+11)a
2 TV2 Female 34 25 (9+10+6)
3 TV3 Male 7 22 (9+5+8)
4 TV4 Female 4 23 (9+9+5)
Group 2 Australia
5 AU1 Male 31 20
6 AU2 Female 28 17
7 AU3 Female 3 19
8 AU4 Male 31 16
9 AU5 Female 31 12
Group 3 Vietnam
10 VN1 Male 34 18
11 VN2 Female 34 18
12 VN3 Male 8 17
13 VN4 Female 5 18
14 VN5 Male 37 19
15 VN6 Male 2 18
16 VN7 Female 6 19
a
the number of samples collected before, during and after travelling to Hanoi
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